Jeemin Yim

532 total citations · 1 hit paper
20 papers, 268 citations indexed

About

Jeemin Yim is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Jeemin Yim has authored 20 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Immunology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Jeemin Yim's work include Cancer Immunotherapy and Biomarkers (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Jeemin Yim is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Jeemin Yim collaborates with scholars based in South Korea, Ethiopia and Puerto Rico. Jeemin Yim's co-authors include Yoon Kyung Jeon, Sehui Kim, Jaemoon Koh, Young A Kim, Doo Hyun Chung, Sung‐Hye Park, Tae Min Kim, Bhumsuk Keam, Soo Jeong Nam and Chan-Young Ock and has published in prestigious journals such as Blood, European Journal of Cancer and Medicine.

In The Last Decade

Jeemin Yim

18 papers receiving 267 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancer

2025 25 citations Hyein Jeong, Jaemoon Koh et al. Journal for ImmunoTherapy of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeemin Yim South Korea	10	156	98	74	61	42	20	268
Víctor Albarrán Spain	10	155 1.0×	67 0.7×	74 1.0×	21 0.3×	25 0.6×	17	284
Katharina Prochazka Austria	7	87 0.6×	59 0.6×	34 0.5×	66 1.1×	30 0.7×	17	252
Д. М. Коновалов Russia	8	64 0.4×	28 0.3×	58 0.8×	63 1.0×	51 1.2×	72	230
Hwa Jin Cho South Korea	9	99 0.6×	61 0.6×	102 1.4×	25 0.4×	47 1.1×	24	321
Zifen Gao China	11	158 1.0×	41 0.4×	59 0.8×	194 3.2×	45 1.1×	22	280
Stefania Kokkali Greece	11	100 0.6×	26 0.3×	89 1.2×	48 0.8×	21 0.5×	38	251
Qi-Chun Cai China	8	193 1.2×	260 2.7×	36 0.5×	128 2.1×	34 0.8×	9	391
Shereen Gheith United States	7	61 0.4×	147 1.5×	18 0.2×	63 1.0×	16 0.4×	17	284
María Ángeles Vaz Salgado Spain	9	125 0.8×	22 0.2×	101 1.4×	28 0.5×	33 0.8×	44	354
Noah Richardson United States	5	193 1.2×	150 1.5×	44 0.6×	11 0.2×	12 0.3×	13	331

Countries citing papers authored by Jeemin Yim

Since Specialization

Citations

This map shows the geographic impact of Jeemin Yim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeemin Yim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeemin Yim more than expected).

Fields of papers citing papers by Jeemin Yim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeemin Yim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeemin Yim. The network helps show where Jeemin Yim may publish in the future.

Co-authorship network of co-authors of Jeemin Yim

This figure shows the co-authorship network connecting the top 25 collaborators of Jeemin Yim. A scholar is included among the top collaborators of Jeemin Yim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeemin Yim. Jeemin Yim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yim, Jeemin, et al.. (2026). Revisiting human sparganosis: a pathologic review from a single institution. Journal of Pathology and Translational Medicine. 60(1). 83–91.

Jeong, Hyein, Jaemoon Koh, Sehui Kim, et al.. (2025). Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancer. Journal for ImmunoTherapy of Cancer. 13(3). e010612–e010612. 25 indexed citations breakdown →

Yim, Jeemin, Hye Eun Park, Jongho Park, et al.. (2025). Case report of extranodal NK/T-cell lymphoma mimicking Behcet syndrome. Medicine. 104(36). e44329–e44329.

Kim, Sehui, Hyein Jeong, Kichang Lee, et al.. (2024). Increased CCL2/CCR2 axis promotes tumor progression by increasing M2 macrophages in MYC/BCL2 double-expressor DLBCL. Blood Advances. 8(22). 5773–5788. 9 indexed citations

Yim, Jeemin, Jiwon Koh, Sehui Kim, et al.. (2024). Clinicopathological implications of immunohistochemical expression of TBX21, CXCR3, GATA3, CCR4, and TCF1 in nodal follicular helper T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified. Journal of Pathology and Translational Medicine. 58(2). 59–71. 2 indexed citations

Kim, Miso, Soyeon Kim, Jeemin Yim, et al.. (2023). Targeting CD73 to Overcomes Resistance to First-Generation EGFR Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer. Cancer Research and Treatment. 55(4). 1134–1143. 4 indexed citations

Yim, Jeemin, et al.. (2023). Prognostic Impact of the Immunoscore Based on Whole-Slide Image Analysis of CD3+ Tumor-Infiltrating Lymphocytes in Diffuse Large B-Cell Lymphoma. Modern Pathology. 36(9). 100224–100224. 9 indexed citations

Yim, Jeemin, Jiwon Koh, Sehui Kim, et al.. (2022). Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System: An Analysis of 11 Cases Using Targeted Gene Sequencing. PubMed Central. 2 indexed citations

Koh, Jaemoon, Sehui Kim, Jeemin Yim, et al.. (2022). TCF1+PD-1+ tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancer. European Journal of Cancer. 174. 10–20. 27 indexed citations

10.

Kim, Sehui, Jaemoon Koh, Jeemin Yim, et al.. (2022). High tumor hexokinase-2 expression promotes a pro-tumorigenic immune microenvironment by modulating CD8+/regulatory T-cell infiltration. BMC Cancer. 22(1). 1120–1120. 14 indexed citations

11.

Kim, Sehui, Jaemoon Koh, Jeemin Yim, et al.. (2021). Comparative analysis of the tumor immune-microenvironment of primary and brain metastases of non-small-cell lung cancer reveals organ-specific and EGFR mutation-dependent unique immune landscape. Cancer Immunology Immunotherapy. 70(7). 2035–2048. 33 indexed citations

12.

Yim, Jeemin, et al.. (2021). Low Density of CD3+ Tumor-Infiltrating Lymphocytes Is Predictive of a Poor Prognosis in Diffuse Large B-Cell Lymphoma Independently of MYC and BCL2 Double Expression Status: A Potential Utility of Immunoscore Based on Whole-Slide Image Analysis. Blood. 138(Supplement 1). 2523–2523. 1 indexed citations

13.

Park, Jin Woo, Jae‐Kyung Won, Jeong Mo Bae, et al.. (2020). Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors. Diagnostic Pathology. 15(1). 114–114. 21 indexed citations

14.

Yim, Jeemin, Jaemoon Koh, Sehui Kim, et al.. (2020). Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non–small-cell lung cancer. European Journal of Cancer. 133. 74–85. 46 indexed citations

15.

Kim, Sehui, Jiwon Koh, Jeemin Yim, et al.. (2020). Immunophenotypic Landscape and Prognosis of Diffuse Large B-Cell Lymphoma with MYC/BCL2 Double Expression: An Analysis of A Prospectively Immunoprofiled Cohort. Cancers. 12(11). 3305–3305. 11 indexed citations

16.

Kim, Seong‐Ik, Beomseok Jeon, Jae‐Kyung Won, et al.. (2019). An Autopsy Proven Case of CSF1R-mutant Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) with Premature Ovarian Failure. Experimental Neurobiology. 28(1). 119–129. 10 indexed citations

17.

Kim, Sehui, Soo Jeong Nam, Changhee Park, et al.. (2019). High tumoral PD-L1 expression and low PD-1 ⁺ or CD8 ⁺ tumor-infiltrating lymphocytes are predictive of a poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system. OncoImmunology. 8(9). e1626653–e1626653. 35 indexed citations

18.

Yim, Jeemin, et al.. (2018). Intracranial Ewing sarcoma with whole genome study. Child s Nervous System. 35(3). 547–552. 11 indexed citations

19.

Yim, Jeemin, et al.. (2018). Primary Peripheral Gamma Delta T-Cell Lymphoma of the Central Nervous System: Report of a Case Involving the Intramedullary Spinal Cord and Presenting with Myelopathy. Journal of Pathology and Translational Medicine. 53(1). 57–61. 4 indexed citations

20.

Kim, Han‐Jun, et al.. (2016). Successful response to imatinib in two dogs with inoperable grade III infiltrating mast cell tumours: a case report. Veterinární Medicína. 61(8). 467–473. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact